Age-related macular degeneration: Beyond anti-angiogenesis

Por Kent, David L.
Publicado em 2014

Against pragmatism: on efficacy, effectiveness and the real world

Por Kent, David M, Kitsios, Georgios
Publicado em 2009

Prevention of Recurrent Stroke in Patients with Patent Foramen Ovale

Por Wessler, Benjamin S., Kent, David M.
Publicado no Neurol Clin (2015)

Controversies in Cardioembolic Stroke

Por Wessler, Benjamin S., Kent, David M
Publicado no Curr Treat Options Cardiovasc Med (2015)

Patent foramen ovale and MRI: Can imaging the brain tell us about the heart?

Por Thaler, David E., Kent, David M.
Publicado em 2009

Patent foramen ovale: Rethinking trial strategies and treatment options

Por Thaler, David E., Kent, David M.
Publicado em 2010

Princeton Conference: Is PFO a Modifiable Risk Factor for Stroke Recurrence?

Por Kent, David M., Thaler, David E.
Publicado em 2010

Aggregating and Disaggregating Patients in Clinical Trials and their Subgroup Analyses

Por Kent, David M., Lindenauer, Peter K
Publicado em 2010

Therapeutic Innovations and Diminishing Returns

Por Kent, David M., Trikalinos, Thomas A.
Publicado em 2009

Are “Treatment” Bare Metal Stents Superior to “Control” Bare Metal Stents? A meta-analytic approach

Por Kent, David M, Trikalinos, Thomas A
Publicado em 2008

Personalizing Evidence-based Primary Prevention with Aspirin: Individualized Risks and Patient Preference

Por Kent, David M., Shah, Nilay D.
Publicado em 2011

The Risk of Paradoxical Embolism (RoPE) Study: Developing risk models for application to ongoing randomized trials of percutaneous patent foramen ovale closure for cryptogenic stro...

Por Kent, David M, Thaler, David E
Publicado em 2011

Percutaneous Closure of Patent Foramen Ovale: A Near-Perfect Treatment Ruined by Careful Study?

Por Kent, David M, Kitsios, Georgios D.
Publicado em 2012

Evidence-Based Medicine and the Hard Problem of Multimorbidity

Por Boyd, Cynthia M., Kent, David M.
Publicado em 2014

Index event bias: an explanation for the paradoxes of recurrence risk research

Por Dahabreh, Issa J., Kent, David M.
Publicado em 2011

Toward an epidemiology of the known unknowns in cryptogenic stroke

Por Dahabreh, Issa J., Kent, David M.
Publicado no Heart (2012)

Still No Closure On the Question of PFO Closure

Por Messé, Steven R., Kent, David M.
Publicado no N Engl J Med (2013)

Ideas and Opinions submission for the Annals of Internal Medicine The Lake Wobegon effect: Why most patients are at below average risk

Por Vickers, Andrew J., Kent, David M.
Publicado no Ann Intern Med (2015)

Personalised medicine: not just in our genes

Por Kitsios, Georgios D, Kent, David M
Publicado no BMJ (2012)

Order Matters: The Order of Somatic Mutations Influences Cancer Evolution

Por Kent, David G., Green, Anthony R.
Publicado no Cold Spring Harb Perspect Med (2017)